264 related articles for article (PubMed ID: 17659706)
21. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.
Andriulli A; Solmi L; Loperfido S; Leo P; Festa V; Belmonte A; Spirito F; Silla M; Forte G; Terruzzi V; Marenco G; Ciliberto E; Sabatino A; Monica F; Magnolia MR; Perri F
Clin Gastroenterol Hepatol; 2004 Aug; 2(8):713-8. PubMed ID: 15290665
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic and pharmacological treatment for prophylaxis against postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis and systematic review.
Vadalà di Prampero SF; Faleschini G; Panic N; Bulajic M
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1415-1424. PubMed ID: 27580214
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Freeman ML
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1354-65. PubMed ID: 17981248
[TBL] [Abstract][Full Text] [Related]
24. [Could nafamostat or gabexate prevent the post endoscopic retrograde cholangiopancreatography pancreatitis?].
Kwon YH; Kim JY; Lee SJ; Jang SY; Park HW; Yang HM; Jung MK; Jeon SW; Cho CM; Tak WY; Kweon YO; Kim SK
Korean J Gastroenterol; 2012 Mar; 59(3):232-8. PubMed ID: 22460572
[TBL] [Abstract][Full Text] [Related]
25. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials.
Rudin D; Kiss A; Wetz RV; Sottile VM
J Gastroenterol Hepatol; 2007 Jul; 22(7):977-83. PubMed ID: 17559376
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
[TBL] [Abstract][Full Text] [Related]
27. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Dumonceau JM; Andriulli A; Elmunzer BJ; Mariani A; Meister T; Deviere J; Marek T; Baron TH; Hassan C; Testoni PA; Kapral C;
Endoscopy; 2014 Sep; 46(9):799-815. PubMed ID: 25148137
[TBL] [Abstract][Full Text] [Related]
28. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone.
Fogel EL; Eversman D; Jamidar P; Sherman S; Lehman GA
Endoscopy; 2002 Apr; 34(4):280-5. PubMed ID: 11932782
[TBL] [Abstract][Full Text] [Related]
29. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study.
Fazel A; Quadri A; Catalano MF; Meyerson SM; Geenen JE
Gastrointest Endosc; 2003 Mar; 57(3):291-4. PubMed ID: 12612504
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Pande H; Thuluvath P
Drugs; 2003; 63(17):1799-812. PubMed ID: 12921486
[TBL] [Abstract][Full Text] [Related]
31. Comparative study of strategies for preventing post-ERCP pancreatitis after early precut sphincterotomy for biliary access.
Ang TL; Kwek AB; Song M; Li JW; Thurairajah PH
J Dig Dis; 2016 Oct; 17(10):692-696. PubMed ID: 27556283
[TBL] [Abstract][Full Text] [Related]
32. Effect of somatostatin in the prevention of pancreatic complications after endoscopic retrograde cholangiopancreatography.
Chan HH; Lai KH; Lin CK; Tsai WL; Lo GH; Hsu PI; Wei MC; Wang EM
J Chin Med Assoc; 2008 Dec; 71(12):605-9. PubMed ID: 19114324
[TBL] [Abstract][Full Text] [Related]
33. [In patients undergoing precut biliary sphincterotomy during endoscopic retrograde cholangiopancreatography (ERCP) to facilitate biliary access, is endoscopic pancreatic duct stenting indicated to prevent pancreatitis?].
Igea Arisqueta F
Gastroenterol Hepatol; 2009 Mar; 32(3):171-2. PubMed ID: 19231033
[No Abstract] [Full Text] [Related]
34. NIH state-of-the-science statement on endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy.
NIH Consens State Sci Statements; 2002 Jan 14-16; 19(1):1-26. PubMed ID: 14768653
[TBL] [Abstract][Full Text] [Related]
35. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography.
Schneider J; Barkin J
Gastrointest Endosc; 1997 May; 45(5):447-8. PubMed ID: 9165340
[No Abstract] [Full Text] [Related]
36. The modified pancreatic stent system for prevention of post-ERCP pancreatitis: a case-control study.
Zhang C; Yang YL; Ma YF; Zhang HW; Li JY; Lin MJ; Shi LJ; Qi CC
BMC Gastroenterol; 2017 Oct; 17(1):108. PubMed ID: 29047328
[TBL] [Abstract][Full Text] [Related]
37. Complications of endoscopic sphincterotomy and their prevention.
Huibregtse K
N Engl J Med; 1996 Sep; 335(13):961-3. PubMed ID: 8782505
[No Abstract] [Full Text] [Related]
38. [Can post-ERCP acute pancreatitis be predicted and prevented?].
Heyries L
Gastroenterol Clin Biol; 2001 Jan; 25(1 Suppl):1S241-6. PubMed ID: 11223596
[No Abstract] [Full Text] [Related]
39. Antiproteases in preventing post-ERCP acute pancreatitis.
Tsujino T; Kawabe T; Omata M
JOP; 2007 Jul; 8(4 Suppl):509-17. PubMed ID: 17625308
[TBL] [Abstract][Full Text] [Related]
40. Preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: what can be done?
Hauser G; Milosevic M; Stimac D; Zerem E; Jovanović P; Blazevic I
World J Gastroenterol; 2015 Jan; 21(4):1069-80. PubMed ID: 25632179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
